Sara Najafi

Transdiagnostic risk of mental disorders in offspring of affected parents: a meta‐analysis of family high‐risk and registry studies

Rudolf Uher, Barbara Pavlová, Joaquim Raduà et al. · World Psychiatry · 2023 · 82 citations · Full text

The first-in-class ERK inhibitor ulixertinib shows promising activity in mitogen-activated protein kinase (MAPK)-driven pediatric low-grade glioma models

Romain Sigaud, Lisa Rösch, Charlotte Gatzweiler et al. · Neuro-Oncology · 2022 · 44 citations · Full text

A randomized, <scp>double‐blind</scp>, <scp>placebo‐controlled</scp>, clinical trial to evaluate the benefits of <scp><i>Nigella sativa</i></scp> seeds oil in reducing cardiovascular risks in hypertensive patients

Parisa Shoaei‐Hagh, Farzaneh Kamelan Kafi, Sara Najafi et al. · Phytotherapy Research · 2021 · 36 citations

Broad-Spectrum HDAC Inhibitors Promote Autophagy through FOXO Transcription Factors in Neuroblastoma

Katharina Körholz, Johannes Ridinger, Damir Krunic et al. · Cells · 2021 · 31 citations · Full text

Rapid In Vivo Validation of HDAC Inhibitor-Based Treatments in Neuroblastoma Zebrafish Xenografts

Jagoda K. Wrobel, Sara Najafi, Simay Ayhan et al. · Pharmaceuticals · 2020 · 30 citations · Full text

Tumor Biology, Vivo Validation, Histone Deacetylase +15